Cost-Effectiveness of Pazopanib Versus Sunitinib in Egyptian Patients with Metastatic Renal Cell Carcinoma From the Health Insurance Perspective: A Markov Model
Elsisi, G., Hassouna, A., Abu Taleb, A., Elmahdawy, M., Ibrahim, S.Volume:
17
Langue:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2014.03.526
Date:
May, 2014
Fichier:
PDF, 80 KB
english, 2014